To cite this paper use one of the standards below:
The design of modified drug release systems is performed aiming the increase of drug concentration at the site of action or absorption, reduce the dose and frequency of administration and variations in plasma levels (DHAWAN et. al, 2004). Among these systems oral nanocarriers intended for oral use are of particular interest for the treatment of chronic degenerative diseases such as cancer (Khafagy et. al, 2007). Oil/water nanoemulsions (NE) were developed and characterized for incorporation of hydrophobic and chitosan-coated chemotherapeutic agents (Q) to confer mucoadhesiveness, protection against premature degradation and increased cell permeability. The NE presented average diameter of 118.3 to 160.4 nm and PDI in the range of 0.13 to 0.20. Due to the presence of soy lecithin the zeta potential was negative between -23.48 and -33.57. After coating with different Q proportions, there was an increase in diameter (>50 nm) and zeta potential inversion, indicating the nanocarriers coating.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper